Study Group: Users of Provue system for blood screening(?)
Council Members in this Study Group: 14
Request a survey with this Study Group
Leading Experts in this Study Group
Director of Pathology
Bellevue Hospital Center
Robert Boorstein, MD, PhD, is the Director of Pathology at Bellevue Hospital and an Associate Professor in the Department of Pathology at New York University School of Medicine. He is also the Medical Director for Pathology and Laboratory Medicine of the South Manhattan Healthcare Network and Northern...
Transfusion Service Director
Hennepin County Medical Center
Jed Gorlin, MD, MBA, is the Medical Director of the Memorial Blood Center of Minnesota and an Associate Professor of Laboratory Medicine and Pediatrics at the University of Minnesota. Dr. Gorlin is also the Transfusion Services Director at Hennepin County Medical Center. His research includes the hematopoietic...
Founder and Senior Pathologist
Chestatee Pathology Associates, PC
John Cochran, MD, is the Chief Executive Officer of Chestatee Pathology Associates, PC (Atlanta, GA). He is the Medical Director of two Atlanta-area hospital laboratories. Dr. Cochran has consulted on the following companies: Genzyme, ePocrates, Cerner, NextGen, AllScripts, GE Healthcare, Immucor, Beckman...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Pathologists (US) | 812 |
| Galileo Users | 13 |
| Pricing Experts on Clinical Lab Testing in the U.S. | 55 |
| Users of Invader DNA Analyte Specific Reagents (US) | 21 |
| Applied Biosystems' SOLiD System Users | 22 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Pharmaceutical companies spend over $10,000 per physician on direct gifts and similar activities. These activities are designed to influence prescribing patterns, and most certainly do. Monitoring sales of drug classes as drugs come off patent, as in anti allergy medications, drugs for acid...
The last several years as seen the growth of financial incentives to stimulate improvements in patient safety and patient outcomes. Clearly society has an interest in improving patient safety, and aligning providers and payers financially is a laudable goal. The use of denied payments raises the...
How much will Abbott contribute to bottom line of GE.What is future of Abbott.
Approval of the Mammaprint is a significant advance clinically, as it is the first FDA approved gene expression test for breast cancer. If it is widely accepted, it would represent one of the highest value cancer diagnostic products. The technology would presumably be extended to other common...
Using DNA tests to predict appropriate warfarin dosages clearly has market potential. However, it is yet to be proven that such testing will significantly reduce the trial and error basis of such, and the article discusses trials that are underway.It should be noted that the causes of underdoses...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Lab, Non-Academic/Community Hospital
- Laboratory, Independent
- Integrated Healthcare Delivery Network (IDN)
- Lab, Academic Medical Center
- Non-Academic Community Hospital or Clinic
- Office Based Private Practice or Clinic
- Other Freestanding Healthcare Facility
Most Common Job Types:
- Director
- Physician - Attending Physician
- Physician - Department Chair
- Medical Director
- Chief Executive Officer
- Manager
- Physician - Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms